Lucid Diagnostics Inc.

1.50
-0.02 (-1.32%)
At close: Mar 24, 2025, 3:59 PM
1.51
0.67%
After-hours: Mar 24, 2025, 06:01 PM EDT

Lucid Diagnostics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 2.43M 377K 500K n/a n/a n/a
Cost of Revenue 8.48M 3.61M 585K n/a n/a n/a
Gross Profit -6.05M -3.24M -85K n/a n/a n/a
Operating Income -48.48M -56.17M -27.42M -8.28M -4.42M -1.13M
Interest Income 424K 88K 659K n/a n/a n/a
Pretax Income -52.67M -56.17M -28.08M -8.28M -4.42M -1.13M
Net Income -52.67M -56.17M -28.74M -8.28M -4.42M -1.13M
Selling & General & Admin 35.66M 39.82M 18.04M 2.84M 958.72K 410.29K
Research & Development 7.25M 11.47M 9.3M 5.44M 3.46M 715.63K
Other Expenses -478K 1.65M n/a n/a n/a n/a
Operating Expenses 42.43M 52.93M 27.33M 8.28M 4.42M 1.13M
Interest Expense 416K 8K 659K n/a n/a n/a
Selling & Marketing Expenses 16.4M 16.13M 5.26M 1.3M n/a -205.14K
Cost & Expenses 50.91M 56.55M 27.92M 8.28M 4.42M 1.13M
Income Tax n/a 1.71M 659K -8.28M -4.42M -1.69M
Shares Outstanding (Basic) 41.76M 36.17M 34.92M 36.99M 36.99M 36.99M
Shares Outstanding (Diluted) 41.76M 36.17M 34.92M 36.99M 36.99M 36.99M
EPS (Basic) -1.26 -1.55 -0.82 -0.22 -0.12 -0.03
EPS (Diluted) -1.26 -1.55 -0.82 -0.22 -0.12 -0.03
EBITDA -49.75M -54.23M -27.41M 482.00 n/a 562.96K
Depreciation & Amortization 2.5M 1.94M 4K 8.28M 4.42M 1.69M